Cancer Control & Population Health

UVA Cancer Center catchment area map

The Cancer Control and Population Health (CCPH) program promotes population health sciences research focused on cancer prevention, access to optimal and effective treatment, and support of cancer survivors. The three overall aims of the CCPH program are to:

  1. Identify molecular, genetic, environmental, or behavioral factors related to cancer risk
  2. Create and implement strategies to reduce cancer risk in our communities
  3. Develop and test methods that can support cancer survivors and reduce cancer burden

Across these aims, the CCPH program is focused on research that highlights health disparities in cancer care and rural access to cancer care, particularly in rural Appalachia. Additionally, the Cancer Center Without Walls (CCWW) research program comprises a novel UVA initiative to reach patients across Virginia to provide quality cancer care and to reduce cancer burden across the state. The CCPH program utilizes the Cancer Control Core and Community  Engagement and Outreach in addressing these research goals.

The Cancer Control Core (CCC) is the primary resource by which CCPH supports its research efforts. Established in 2014, the CCC has been led by Dr. Rajesh Balkrishnan to support population-based cancer control research at UVA. The Core provides expert advice and support in three areas: community-based research support, data services, and study design and measure development. 

The Cancer Center’s Community Outreach and Engagement team provides community cancer resources and also assists with and promotes CCPH population research. This team provides community cancer education and service programs and activities aimed at promoting cancer prevention and survivor support. Through the CCC, Outreach and Engagement supports researchers by serving as a liaison with community partners to promote, recruit, and assist with research studies.

CCPH is led by Roger Anderson, PhD and Wendy Cohn, PhD. The program is represented by a wide variety of research interests and expertise across the Cancer Center and UVA Health System.

Read more about program members and their research interests.


Webinar: An Overview of Screening and Prevention Interventions for Rural Populations: What Has Worked 

February 15, 2019 | 12:00 p.m.-1:00 p.m. 

The UVA Cancer Center invites you to participate in a webinar as faculty from both the UVA School of Nursing and Public Health Sciences explore previous screening and prevention interventions that have been successful in rural communities and how the presented interventions (and ones like them) might fit in your own community.

All are welcome to join this webinar. To register, email Lindsay Hauser.

CCPH Seminar Series

Lorraine Dean

Guest speaker, Lorraine Dean

Thursday, February 28 | 12:00-1:30 p.m.

Pinn Hall 2ABC

Join us for our first CCPH program seminar and meeting of 2019. Following programmatic news and updates, Lorraine Dean, Assistant Professor of Epidemiology at Johns Hopkins’ Bloomberg School of Public Health, will be presenting her work, “Long-term Economic Burden of Breast Cancer and its Adverse Effects.” Her talk will present the results of new mixed-methods research on the long-term costs – from out-of-pocket costs and productivity losses to relationships with consumer credit – of breast cancer and breast cancer-related lymphedema, a common adverse effect of breast cancer.

All are welcome to attend, and lunch will be provided.

CCPH 2019 Pilot Grant Cycle 

Thank you to the applicants who submitted proposals for this year’s active cycle of CCPH pilot grant funding for new initiatives in population-based cancer research. Reviews are underway and funding decisions will be announced February 28 at the next CCPH seminar (see details above). 

Opioid Adherence Among Breast Cancer Patients 

Drs. Raj Balkrishnan, Leslie Blackhall and Virginia LeBaron’s recent publication in Breast Cancer Research and Treatment highlights the lack of adherence to breast cancer treatment due to the stigmas associated with opioid use.